James C. Wade, MD

Articles by James C. Wade, MD

Current Issues in the Treatment of Resistant Bloodstream Infections

ByJames C. Wade, MD,Donald H. Batts, MD,John N. Greene, MD,David C. Linch, MD,Georg Maschmeyer, MD, PhD,Carole B. Miller, MD,Gary A. Noskin, MD,Patricia Ribaud, MD,Kenneth V. I. Rolston, MD,Kent A. Sepkowitz, MD,James A. Talcott, MD

August 1st 2000

Bloodstream infections cause significant morbidity and mortality for patients with hematologic malignancy. Antimicrobial drugs are the most reliable currently available treatment for infection, but several issues must be

Latest Updated Articles

Current Issues in the Treatment of Resistant Bloodstream Infections
Published: August 1st 2000 | Updated:

James C. Wade, MD

Articles by James C. Wade, MD

Current Issues in the Treatment of Resistant Bloodstream Infections

Latest Updated Articles

Trending on CancerNetwork

ASH 2025: Key Anticipated Updates in the Leukemia Landscape

ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?

Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma

Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL

Survival Benefit Seen With Cilta-Cel in Earlier Lines of Myeloma Treatment